Alnylam Pharmaceuticals, a RNAi therapeutics company, announced that the US Food and Drug Administration (FDA) has granted fast track designation to patisiran (ALN-TTR02) for the treatment of transthyretin (TTR)-familial amyloid ...
Tags: Alnylam, Fast Track Designation
US-based TransCelerate BioPharma is launching three new global initiatives to further advance efficiency in clinical trials and accelerate the development of new medicines: creation of common clinical trial protocol templates, development ...
Tags: TransCelerate, clinical trial, Global Initiative, Cubist Pharmaceuticals
HomeCare Connect has created an app to reduce the lag times in home health reporting that hinder workers’compensation claims decisions and unnecessarily delays care for injured workers. "In today's work comp environment adjusters ...
Tags: HomeCare Connect, home health, dme reporting, workers'compensation
For many industries, innovation helps to drive down product prices. Over the past few decades, entry-level computers have decreased in price from thousands of dollars to only a few hundred. 1980 saw the debut of IBM's personal computer, ...
The US Food and Drug Administration (FDA) has approved Roche's new drug Gazyva (obinutuzumab) in combination with chlorambucil chemotherapy for treatment of patients with chronic lymphocytic leukemia (CLL) who have not previously been ...
Tags: Combination Vaccine, Medicine
US-based Boston Scientific has obtained Chinese Food and Drug Administration (FDA) approval for its Alair bronchial thermoplasty system, designed for patients suffering from severe asthma. The Alair system uses mild heat to reduce the ...
Tags: Boston Scientific, Alair bronchial thermoplasty system
Alzheon announced the launch of the company, the securing of initial private financing, and the signing of an exclusive license agreement to a novel clinical drug candidate for Alzheimer’s disease, a family of analogs, and a drug ...
Tags: Alzheon, Alzheimer's Disease
MDI Achieve, a provider of electronic health record solution MatrixCare, and WoundRounds, a solution for wound management and risk prevention, have announced a partnership for providing superior clinical and economic outcomes. WoundRounds ...
Cardiovascular Systems, a US-based medical device company, has obtained a premarket approval from the US Food and Drug Administration (FDA) for its Diamondback 360 coronary orbital atherectomy system (OAS), designed to treat severely ...
Kryptiq, a privately held software company, has announced the release of new version of its population health management solution, CareManager 4.0. Co-developed with leading healthcare organizations, and curated in collaboration with a ...
Tags: Kryptiq, Population Health
US-based clinical development firm AltheRx Pharmaceuticals has received a notice of allowance for its patent application from the US Patent and Trademark Office (USPTO) for the use of solabegron in combination with antimuscarinics at both ...
Biotronik, a manufacturer of cardio and endovascular medical devices, has announced that its DREAMS scaffold (DRug Eluting Absorbable Metal Scaffold) has been successfully implanted in the first coronary artery disease patient in Germany as ...
Tags: Biotronik, medical devices
Biopharmaceutical company Trigemina will deliver clinical data on its drug candidate TI-001 for the treatment of chronic migraine at the ongoing 7th Annual Pain Therapeutics Summit East in Boston, Massachusetts. The presentation will ...
Tags: Migraine Drug, Medicine
US-based Sapheon has submitted the first module of pre-market approval (PMA) application to the US Food and Drug Administration (FDA) for its VenaSeal sapheon closure system, designed to treat venous reflux (varicose veins) disease. This ...
Tags: PMA Application, Medicine
A multiple-sclerosis drug that was at the center of Sanofi SA's SAN.FR +1.12% $20 billion takeover battle for Genzyme Corp. three years ago was approved for sale in Europe on Tuesday, the drug's first regulatory approval world-wide. The ...